A simultaneous population pharmacokinetic analysis of rifampicin in Malawian adults and children

Abstract

The popPK model developed can be used to optimize rifampicin exposures through dosing simulations. WHO dosing recommendations may not be achieved using currently licensed fixed dose combination formulations of TB therapy.